Merit Medical Systems Files 8-K
Ticker: MMSI · Form: 8-K · Filed: Jan 14, 2025 · CIK: 856982
| Field | Detail |
|---|---|
| Company | Merit Medical Systems Inc (MMSI) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
Related Tickers: MMSI
TL;DR
MMSI filed an 8-K on Jan 13th, check for financial updates.
AI Summary
Merit Medical Systems, Inc. filed an 8-K on January 14, 2025, reporting events as of January 13, 2025. The filing pertains to Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. Specific financial details or operational updates were not provided in this excerpt.
Why It Matters
This 8-K filing indicates that Merit Medical Systems, Inc. is disclosing important information regarding its financial condition and operations to the public.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting operational and financial information, not indicating any immediate negative events.
Key Players & Entities
- MERIT MEDICAL SYSTEMS INC (company) — Registrant
- 0000856982-25-000003 (filing_id) — Accession Number
- January 13, 2025 (date) — Date of earliest event reported
- January 14, 2025 (date) — Filing Date
- Utah (location) — State of Incorporation
- 87-0447695 (tax_id) — IRS Employer Identification No.
- 1600 West Merit Parkway (address) — Principal executive offices
- South Jordan (location) — City of principal executive offices
- 84095 (zip_code) — Zip code of principal executive offices
FAQ
What specific information is being disclosed in the 8-K filing regarding Merit Medical Systems, Inc.'s results of operations and financial condition?
The provided excerpt does not contain specific details about the results of operations or financial condition, only that these are the subject items of the 8-K filing.
What is the accession number for this 8-K filing?
The accession number for this filing is 0000856982-25-000003.
On what date was this 8-K filing submitted to the SEC?
The filing was submitted as of January 14, 2025.
What is the principal executive office address for Merit Medical Systems, Inc.?
The principal executive office is located at 1600 West Merit Parkway, South Jordan, Utah 84095.
What are the main items covered by this 8-K filing?
This 8-K filing covers Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 669 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-01-13 20:12:35
Filing Documents
- mmsi-20250114x8k.htm (8-K) — 46KB
- mmsi-20250114xex99d1.htm (EX-99.1) — 71KB
- mmsi-20250114x8k001.jpg (GRAPHIC) — 11KB
- mmsi-20250114xex99d1001.jpg (GRAPHIC) — 28KB
- 0000856982-25-000003.txt ( ) — 313KB
- mmsi-20250114.xsd (EX-101.SCH) — 3KB
- mmsi-20250114_lab.xml (EX-101.LAB) — 15KB
- mmsi-20250114_pre.xml (EX-101.PRE) — 9KB
- mmsi-20250114x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition . On January 13, 2025, Merit Medical Systems, Inc. (the "Company") issued a press release reporting its preliminary unaudited revenue earned for the year ended December 31, 2024 and plans to announce its fourth quarter and year end 2024 financial results and fiscal year 2025 guidance. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. The preliminary revenue information presented in the press release is based upon the Company's current expectations and may be adjusted as a result of, among other things, completion of customary financial review and audit procedures.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure . The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K (including the exhibit attached hereto) is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act. The Company makes reference to a non-GAAP financial measure in the press release attached as Exhibit 99.1 to this report. Reconciliation of this non-GAAP financial measure to the comparable GAAP financial measure is included in the press release. 2
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Press Release, dated January 13, 2025, entitled "Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025". 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: January 14, 2025 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 3